Allied Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$577K Hold
2,292
0.07% 71
2026
Q1
$498K Hold
2,292
0.07% 66
2025
Q4
$524K Hold
2,292
0.08% 65
2025
Q3
$531K Buy
2,292
+452
+25% +$92K 0.08% 64
2025
Q2
$342K Hold
1,840
0.06% 70
2025
Q1
$386K Hold
1,840
0.07% 62
2024
Q4
$327K Buy
1,840
+565
+44% +$104K 0.07% 64
2024
Q3
$252K Hold
1,275
0.05% 65
2024
Q2
$219K Sell
1,275
-279
-18% -$46.2K 0.05% 67
2024
Q1
$283K Buy
1,554
+224
+17% +$38.6K 0.07% 55
2023
Q4
$206K Buy
+1,330
New +$194K 0.06% 61
2023
Q2
Sell
-1,275
Closed -$203K 60
2023
Q1
$203K Hold
1,275
0.06% 56
2022
Q4
$206K Buy
+1,275
New +$195K 0.06% 55
2022
Q2
Sell
-1,290
Closed -$209K 56
2022
Q1
$209K Buy
+1,290
New +$187K 0.07% 57
2018
Q3
Sell
-2,843
Closed -$263K 45
2018
Q2
$263K Buy
2,843
+300
+12% +$29.3K 0.21% 43
2018
Q1
$241K Buy
2,543
+100
+4% +$11K 0.2% 44
2017
Q4
$236K Buy
+2,443
New +$230K 0.2% 42

Other funds holding ABBV

Allied Investment Advisors's ABBV Position: Q2 2026 in Review

Allied Investment Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 2,292 shares worth $577K. The position accounts for 0.07% of the portfolio, ranked #71.

Allied Investment Advisors first reported a position in ABBV in Q4 2017 and has held it in 17 quarters since. 2,049 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Allied Investment Advisors held 2,292 shares of AbbVie worth $577K as of Q2 2026.
  • Allied Investment Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.07% of Allied Investment Advisors's portfolio in Q2 2026, its #71 holding.
  • Allied Investment Advisors first reported a position in AbbVie in Q4 2017 and has held it in 17 quarters since.
  • 2,049 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Allied Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.